Environmental risk factors for prevention and molecular intervention of cervical cancer

International Journal of Hygiene and Environmental Health

Volumn 210, Issue 6, 2007, Pages 671-678

  Au, William W ^a   Abdou Salama, Salama ^a   Sierra Torres, Carlos H ^b   Al Hendy, Ayman ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD DEL CAUCA   (Colombia)

Author keywords

Cancer prevention; Cervical cancer; Cigarette smoking; Dominant negative estrogen receptor; Estrogen; Gene therapy; HPV infection; Molecular therapy; SiRNA

Indexed keywords

HUMAN PAPILLOMAVIRUS;

EID: 36049021981     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2006.10.003     Document Type: Article

References (65)

1. Al Moustafa A., Fulkes W.D., Wong A., Jalla H., Batist G., Yu Q., Herlyn M., Sicinski P., and Alaoyi-Jamali M.A. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene 23 (2004) 5252-5256
2. Al-Hendy A., Lee E.J., Wang H.Q., and Copland J.A. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am. J. Obstet. Gynecol. 191 (2004) 1621-1631
3. Almadori G., Calli J., Cadoni G., Bussu F., and Maurizi M. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head & Neck 24 (2002) 597-604
4. Au W.W. Life style, environmental and genetic susceptibility to cervical cancer. Toxicology 198 (2004) 117-120
5. Au W.W., Sierra-Torres C.H., and Tyring S.K. Acquired and genetic susceptibility to cervical cancer. Mutat. Res. 544 (2003) 361-364
6. Au W.W., Salama A.S., Sierra-Torres H., and Al-Hendy . Risk factors to and molecular intervention of cervical cancer. Mutat. Res. 577 S1 (2005) 491
7. Au, W.W., Abdou-Salama, S., Al-Hendy, A., 2006. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene. Gynecol. Oncol., in press.
8. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 Suppl. 1 (2005) S16-S24
9. Brake T., and Lambert P.F. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc. Natl. Acad. Sci. USA 103 (2005) 2490-2495
10. Brewer J., Benghuzzi H., and Tucci M. The role of route of estrogen administration on the proliferation of SiHa cells in culture. Biomed. Sci. Instrum. 41 (2005) 68-73
11. Brinton L.A., Schairer C., Haenszel W., Stolley P., Lehman H.F., Levine R., and Savitz D.A. Cigarette smoking and invasive cervical cancer. J. Am. Med. Assoc. 255 (1986) 3265-3269
12. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., and Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22 (2003) 5938-5945
13. Campbell K. Preventing cervical cancer by vaccinating against HPV. Nurs. Times 101 (2005) 21-22
14. Chen D., Carter T.H., and Auborn K.J. Apoptosis of cervical cancer cells: implications for adjunct antiestrogen therapy for cervical cancer. Anticancer Res. 24 (2004) 2649-2656
15. Chen T.M., Pecoraro G., and Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53 (1993) 1167-1171
16. Chien P.Y., Ito M., Park Y., Tagami T., Gehm B.D., and Jameson J.L. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Mol. Endocrinol. 13 (1999) 2122-2136
17. Curiel D.T. Gene therapy for carcinoma of the breast: genetic ablation strategies. Breast Cancer Res. 2 (2000) 45-49
18. Dao D.D., Sierra-Torres C.H., Robazetti S.C., Naranjo de Gomez M., Konig R., Lester J., Au W.W., and Tyring S.K. HLA-DQB1 alleles and cervical cancer in Venezuela women. Gynecol. Oncol. 96 (2005) 349-354
19. Duensing S., and Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int. J. Cancer 109 (2004) 157-162
20. Elson D.A., Riley R.R., Lacey A., Gudmundur T., Talamantes F.J., and Arbeit J.M. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res. 60 (2000) 1267-1275
21. Hallenbeck P.L., and Stevenson S.C. Targetable gene delivery vectors. Adv. Exp. Med. Biol. 465 (2000) 37-46
22. Hellberg D., Valentin J., and Nilsson S. Smoking and cervical intraepithelial neoplasia. An association independent of sexual and other risk factors?. Acta Obstet. Gynecol. Scand. 65 (1986) 625-631
23. Hellberg D., Nilsson S., Haley N.J., Hoffman D., and Wynder E. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am. J. Obstet. Gynecol. 158 (1988) 910-913
24. Horner S.M., DeFilippis R.A., Manuelidies L., and DeMaio D. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. J. Virol. 78 (2004) 4063-4073
25. Huang F.Y., Kwok Y.K., Lau E.T., Tang M.H., Ng T.Y., and Ngan H.Y. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas. Cancer Genet. Cytogenet. 157 (2005) 42-48
26. Ince B.A., Zhuang Y., Wrenn C.K., Shapiro D.J., and Katzenellenbogen B.S. Powerful dominant negative mutants of the human estrogen receptor. J. Biol. Chem. 268 (1993) 14026-14032
27. Ince B.A., Schodin D.J., Shapiro D.J., and Katzenellenbogen B.S. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 136 (1995) 3194-3199
28. Jiang M., Rubbi C.P., and Milner J. Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis. Oligonucleotides 14 (2004) 239-248
29. Kim C.J., Um S.J., Kim T.Y., Kim E.J., Park T.C., Kim S.J., Namkoong S.E., and Park J.S. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells. Int. J. Gynecol. Cancer 10 (2000) 157-164
30. Kjellberg L., Hallmans G., Ahren A.M., Johansson R., Bergman F., Wadell G., Angstrom T., and Dillner J. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br. J. Cancer 82 (2000) 1332-1338
31. Lakhani S.A., Masud A., Kuida K., Porter G.A., Booth C.J., Mehal W.Z., Inayat I., and Flavell R.A. Caspases 3 and 7: key mediators of mitochondrial events in apoptosis. Science 311 (2006) 847-851
32. Lazennec G., Alcorn J.L., and Katzenellenbogen B.S. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. Mol. Endocrinol. 13 (1999) 969-980
33. Lee E.J., Duan W.R., Jakacka M., Gehm B.D., and Jameson J.L. Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142 (2001) 3756-3763
34. Lee K.H., Yim E.K., Kim C.J., Namkoong S.E., Um S.J., and Park J.S. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol. Oncol. 98 (2005) 45-53
35. Maciag P.C., Schlecht N.F., Souza P.S., Franco E.K., Villa L.L., and Petzl-Erler M.L. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epi. Biom. Prev. 9 (2000) 1183-1191
36. Mehes G., Speich N., Bollmann M., and Bollmann R. Chromosomal aberrations accumulate in polyploid cells of high grade squamous intraepithelial lesions (HSIL). Pathol. Oncol. Res. 10 (2004) 142-148
37. Moodley M., Sewart S., Herrington C.S., Chetty R., Pegoraro R., and Moodley J. The interaction between steroid hormones, human papillomavirus type 16, E6 oncogene expression, and cervical cancer. Int. J. Gynecol. Cancer 13 (2003) 834-842
38. Moreno V., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., Wlaboomers J.M., and Franceschi S. Lancet 359 (2002) 1085-1092
39. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., and Owens M. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78 (2004) 451-460
40. Munoz N., Bosch X., De Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
41. Nair H.B., Luthra R., Kirma N., Liu Y.G., Flowers L., Evans D., and Tekmal R.R. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res. 65 (2005) 11164-11173
42. Olaharski A.J., Sotelo R., Solorza-Luna G., Gonsebatt M.E., Guzman P., Mohar A., and Eastmond D.A. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27 (2006) 337-343
43. Park J.S., Rhyu J.W., Kim C.J., Kim H.S., and Lee S.Y. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen. Gynecol. Oncol. 89 (2003) 360-368
44. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol. 2 (2001) 533-543
45. Pett M.R., Alazawi W.O., Roberts I., Dowen S., Smith D.I., Stanley M.A., and Coleman N. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 64 (2004) 1359-1368
46. Prokopczyk B., Coz J.E., Hoffmann D., and Waggoner S.E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non-smokers. J. Natl. Cancer Inst. 89 (1997) 868-873
47. Putral L.N., Bywater M.J., Gu W., Saunders N.A., Gabrielli B.G., Leggatt G.R., and McMillan N.A. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol. Pharmacol. 68 (2005) 1311-1319
48. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
49. Saxena A., Yahsar C., Taylor D.D., and Gercel-Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am. J. Obstet. Gynecol. 192 (2005) 1339-1340
50. Schiff R., Massarweh S.A., Shou J., Bharwani L., Arpino G., Rimawi M., and Osborne C.K. Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother. Pharmacol. 56 S1 (2005) s10-s20
51. Schiffman M., and Castle P.E. The promise of global cervical cancer prevention. New Engl. J. Med. 353 (2005) 2101-2108
52. Schneider A., Kirchhoff T., Meinhardt G., and Gissmann L. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet. Gynecol. 79 (1992) 683-688
53. Sengupta S., and Wasylyk B. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann. NY Acad. Sci. 1024 (2004) 54-71
54. Sierra-Torres C.H., Tyring S.J., and Au W.W. Risk contribution of sexual behavior and cigarette smoking to cervical neoplasia. Int. J. Gynecol. Cancer 13 (2003) 617-625
55. Sierra-Torres C.H., Au W.W., Arrastia C.D., Cajas-Salazar N., Robazetti S.C., Payne D.A., and Tyring S.K. Polymorphisms for CYP2E1, GSTM1, and mEH, and the risk for cervical neoplasia. Environ. Mol. Mutagen. 41 (2003) 69-76
56. Sierra-Torres C.H., Arboleda-Moreno Y.Y., and Orejuela-Aristizabal L. Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia. Environ. Mol. Mutag. 47 (2006) 553-561
57. Simons A.M., Phillips D.H., and Coleman D.V. Damage to DNA in cervical epithelium related to smoking tobacco. Br. Med. J. 306 (1993) 1444-1448
58. Slattery M.L., Robison L.M., Schuman K.L., French T.K., Abbott T.M., Overall Jr J.C., and Gardner J.W. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. J. Am. Med. Assoc. 262 (1989) 499-509
59. Snijders P.J., Steenbergen R.D., Heideman D.A., and Meijer C.J. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J. Pathol. 208 (2006) 152-164
60. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., and Green D.R. Connected to death: the (unexpected) mitochondrial pathway of apoptosis. Science 310 (2005) 66-68
61. Vandepapeliere P., Barrasso R., Meijer C.J., Walboomers J.M., Wettendorff M., Stanberry L.R., and Lacey C.J. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: Infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J. Infect. Dis. 192 (2005) 2099-2107
62. Velema J.P., Ferrera A., Figueroa M., Bulnes R., Toro L.A., De Barahona O., Claros J.M., and Mechers W.J. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int. J. Cancer 97 (2002) 536-541
63. Vousden K.H. P53 and PUMA: a deadly duo. Science 309 (2005) 1685-1686
64. Yamato K., Fen J., Kobuchi H., Nasu Y., Yamada T., and Nishihara T. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. Cancer Gene Ther 13 (2006) 234-241
65. You H., Lui Y., Prasad C.K., Agrawal N., Zhang D., Bandyopadhyay S., Liu H., Kay H.H., Mehta J.L., and Hermonat P.L. Multiple human papillomavirus genes affect the adeno-associated virus life cycle. Virology 344 (2006) 532-540